Most Recent Articles about Pacific Biosciences of California
Pacific Biosciences of California (PACB) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release http://www.zacks.com/stock/news/351258/pacific-biosciences-of-california-pacb-may-report-negative-earnings-know-the-trend-ahead-of-next-weeks-release?cid=CS-ZC-FT-351258 Jan 31, 2019 - Pacific Biosciences (PACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LMNX or PACB: Which is a Better MedTech Investment Pick? http://www.zacks.com/stock/news/345680/lmnx-or-pacb-which-is-a-better-medtech-investment-pick?cid=CS-ZC-FT-345680 Jan 04, 2019 - Luminex (LMNX) scores higher than Pacific Biosciences (PACB) considering growth projections and fundamentals.
An Easy Way To Arbitrage Profits: The GDL Fund https://seekingalpha.com/article/4229948-easy-way-arbitrage-profits-gdl-fund?source=feed_tag_editors_picks Dec 24, 2018 - Strategy for profiting in up, sideways, or down markets. Capture a double discount – deal spreads plus retail investor panic. This worked well in 2009 and could work well in 2019.

Related Companies

Name Exchange Price Mkt Cap
QTRX Quanterix Corporation NASDAQ $16.52 $365.09M
FLDM Fluidigm Corporation NASDAQ $8.01 $313.7M
AXDX Accelerate Diagnostics, Inc. NASDAQ $21 $1.14B
HBIO Harvard Bioscience, Inc. NASDAQ $5.35 $195.7M
EYPT EyePoint Pharmaceuticals, Inc. NASDAQ $2.35 $175.1M
Sector: Capital Goods > Industry: Biotechnology: Laboratory Analytical Instruments